Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28865074 | 0.96 | CA1 (0.33) | CA1CA2 | |
| Fluoride SCHEMBL27321968 | 0.96 | CA1 (0.33) | CA1CA2 | |
| Butane SCHEMBL2384826 | 0.93 | CA1 (0.35) | CA1CA2 | |
| Butane SCHEMBL2384822 | 0.93 | CA1 (0.35) | CA1CA2 | |
| SCHEMBL27541078 | 0.85 | CA1 (0.32) | CA1CA2 | |
| Acetic Acid SCHEMBL21681585 | 0.84 | FFAR3 (0.41) | — | |
| SCHEMBL18126344 | 0.84 | FAAH (0.35) | CA2 | |
| SCHEMBL10747079 | 0.82 | CA1 (0.30) | CA1CA2 | |
| SCHEMBL1043228 | 0.82 | USP2 (0.39) | CA1CA2 | |
| SCHEMBL11842047 | 0.82 | USP2 (0.32) | CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 447 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4738518-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | Central Glass Company, Limited (JP) | 2026-05-06 | — | — | EP | claimed |
| EP-4738517-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY | Central Glass Company, Limited (JP) | 2026-05-06 | — | — | EP | claimed |
| CN-121586956-A | Nonaqueous electrolyte and nonaqueous electrolyte using the same nonaqueous electrolyte battery of aqueous electrolyte | 中央硝子株式会社 | 2026-02-27 | — | — | CN | claimed |
| US-12227510-B2 | Crystal form of acid addition salt of furopyrimidine compound | HANMI PHARM. CO., LTD. (KR) | 2025-02-18 | — | — | US | claimed |
| WO-2025028449-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | セントラル硝子株式会社 | 2025-02-06 | — | — | WO | claimed |
| WO-2025028448-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY | セントラル硝子株式会社 | 2025-02-06 | — | — | WO | claimed |
| CN-118993949-A | Preparation method of pentafluorophenol ethyl sulfonate used as electrolyte additive | 海科新源材料科技(湖北)有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-117936900-A | Battery preparation method for inhibiting sodium ion battery gas production, local high-concentration electrolyte and sodium ion battery thereof | 广东钠壹新能源科技有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-117304253-A | Preparation method and application of diazabicyclo-peptoid derivative | 中国药科大学 | 2023-12-29 | — | — | CN | claimed |
| WO-2023246631-A1 | PREPARATION METHOD FOR DIAZABICYCLO PEPTIDOMIMETIC DERIVATIVE AND USE THEREOF | 中国药科大学 | 2023-12-28 | — | — | WO | claimed |
| US-20170197914-A1 | METHOD FOR PREPARING AN AROMATIC SULFIDE OR SALT THEREOF | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2017-07-13 | — | — | US | claimed |
| EP-3190139-A1 | METHOD FOR PREPARING AN AROMATIC SULFIDE OR SALT THEREOF | Industrial Technology Research Institute (TW) | 2017-07-12 | — | — | EP | claimed |
| CN-103694195-A | Heterocyclic aromatic micromolecule organic compounds and derivatives, preparation method and medical application | UNIV EAST CHINA NORMAL | 2014-04-02 | — | — | CN | claimed |
| US-20120157683-A1 | PROCESS FOR THE PREPARATION OF DUTASTERIDE | AUROBINDO PHARMA LTD (IN) | 2012-06-21 | — | — | US | claimed |
| US-8106224-B2 | Stereospecific method for the preparation of dioxa-bicyclooctane nitrate compounds | LACER, S.A. (ES) | 2012-01-31 | — | — | US | claimed |
| WO-2011004242-A2 | AN IMPROVED PROCESS FOR THE PREPARATION OF DUTASTERIDE | AUROBINDO PHARMA LIMITED (IN) | 2011-01-13 | — | — | WO | claimed |
| US-20100160652-A1 | STEREOSPECIFIC METHOD FOR THE PREPARATION OF DIOXA-BICYCLOOCTANE NITRATE COMPOUNDS | LACER, S.A. (ES) | 2010-06-24 | — | — | US | claimed |
| US-7498431-B2 | Process for the preparation of chiral azetidinones | FRAMROZE BOMI PATEL | 2009-03-03 | — | — | US | claimed |
| US-20070129540-A1 | Process for the preparation of chiral azetidinones | OPUS ORGANICS PVT LIMITED (IN) | 2007-06-07 | — | — | US | claimed |
| US-6828448-B2 | 2-butyl-5-(methanesulfonamido)benzofuran; preparation of dronedarone | SANOFI-SYNTHELABO (FR) | 2004-12-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170197914-A1 | METHOD FOR PREPARING AN AROMATIC SULFIDE OR SALT THEREOF | C1S, ARSA, TST | CA1 1781/4885CA2 611/4885 |
| US-20100160652-A1 | STEREOSPECIFIC METHOD FOR THE PREPARATION OF DIOXA-BICYCLOOCTANE NITRATE COMPOUNDS | TST, NOS3, NOS1 | CA1 130/4885CA2 54/4885 |
| US-20070129540-A1 | Process for the preparation of chiral azetidinones | CYP1B1, ALDH7A1, CYP3A5 | CA1 3251/4885CA2 3896/4885 |
| US-20120157683-A1 | PROCESS FOR THE PREPARATION OF DUTASTERIDE | CYP21A2, CYP17A1, HSD17B7 | CA1 525/4885CA2 379/4885 |
| US-12227510-B2 | Crystal form of acid addition salt of furopyrimidine compound | DPYD, ACR, ATIC | CA1 1091/4885CA2 486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.